{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:52:55Z","timestamp":1761515575699,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.4158\/ep.14.1.6","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T22:03:13Z","timestamp":1365199393000},"page":"6-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The D-Lemia for Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Michael F.","family":"Holick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.14.1.6_bb0005","first-page":"215","article-title":"Unique biosynthesis by kidney of a biologically active vitamin D metabolite","volume":"39","author":"Fraser","year":"1981","journal-title":"Nature."},{"key":"10.4158\/EP.14.1.6_bb0010","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1073\/pnas.68.4.803","article-title":"Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine","volume":"68","author":"Holick","year":"1971","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.4158\/EP.14.1.6_bb0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"New Engl J Med."},{"key":"10.4158\/EP.14.1.6_bb0020","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol."},{"issue":"Suppl 5","key":"10.4158\/EP.14.1.6_bb0025","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/ajkd.2001.28111","article-title":"Therapeutic uses of vitamin D analogues","volume":"38","author":"Brown","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.14.1.6_bb0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","article-title":"Renal osteodystrophy","volume":"333","author":"Hruska","year":"1995","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.14.1.6_bb0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-199707000-00004","article-title":"Regulation of parathyroid cell proliferation","volume":"6","author":"Silver","year":"1997","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"10.4158\/EP.14.1.6_bb0040","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest."},{"key":"10.4158\/EP.14.1.6_bb0045","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ki.1992.404","article-title":"Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol","volume":"42","author":"Gallieni","year":"1992","journal-title":"Kidney Int."},{"key":"10.4158\/EP.14.1.6_bb0050","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca \u00d7 PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"10.4158\/EP.14.1.6_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.ki.5001542","article-title":"Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study","volume":"70","author":"Melamed","year":"2006","journal-title":"Kidney Int."},{"key":"10.4158\/EP.14.1.6_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI112304","article-title":"Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans","volume":"77","author":"Portale","year":"1986","journal-title":"J Clin Invest."},{"key":"10.4158\/EP.14.1.6_bb0065","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/j.ajkd.2004.01.012","article-title":"Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4","volume":"43","author":"Coburn","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.14.1.6_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mlc.2002.122819","article-title":"Differential effects of 19-nor-1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 on intestinal calcium and phosphate transport","volume":"139","author":"Brown","year":"2002","journal-title":"J Lab Clin Med."},{"issue":"Suppl 1","key":"10.4158\/EP.14.1.6_bb0075","first-page":"S11","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis."},{"issue":"Suppl 3","key":"10.4158\/EP.14.1.6_bb0080","first-page":"S1","article-title":"National Kidney Foundation, K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.14.1.6_bb0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4158\/EP.14.1.18","article-title":"Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"14","author":"Andress","year":"2008","journal-title":"Endocr Pract."},{"key":"10.4158\/EP.14.1.6_bb0090","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1210\/jc.2002-021356","article-title":"Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors--new prospects for treatment of hyperparathyroidism with vitamin D","volume":"87","author":"Correa","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.1.6_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000098561","article-title":"Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease","volume":"27","author":"Zisman","year":"2007","journal-title":"Am J Nephrol."},{"key":"10.4158\/EP.14.1.6_bb0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1525-139X.2005.18402.x","article-title":"Vitamin D for health and in chronic kidney disease","volume":"18","author":"Holick","year":"2005","journal-title":"Semin Dial."},{"key":"10.4158\/EP.14.1.6_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4158\/EP.14.1.10","article-title":"Efficacy of cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study","volume":"14","author":"Chandra","year":"2008","journal-title":"Endocr Pract."},{"key":"10.4158\/EP.14.1.6_bb0110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/77.1.204","article-title":"Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol [erratum in Am J Clin Nutr. 2003;78:1047]","volume":"77","author":"Heaney","year":"2003","journal-title":"Am J Clin Nutr."},{"key":"10.4158\/EP.14.1.6_bb0115","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/ajcn\/77.6.1478","article-title":"Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health","volume":"77","author":"Tangpricha","year":"2003","journal-title":"Am J Clin Nutr."},{"key":"10.4158\/EP.14.1.6_bb0120","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ajcn\/68.4.854","article-title":"Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2","volume":"68","author":"Trang","year":"1998","journal-title":"Am J Clin Nutr."},{"key":"10.4158\/EP.14.1.6_bb0125","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1210\/jc.2004-0360","article-title":"Vitamin D2 is much less effective than vitamin D3 in humans","volume":"89","author":"Armas","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.1.6_bb0130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0304-4165(76)90339-1","article-title":"Vitamin D metabolite-binding proteins in human tissue","volume":"444","author":"Haddad","year":"1976","journal-title":"Biochem Biophys Acta."},{"key":"10.4158\/EP.14.1.6_bb0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0002-9343(74)90767-0","article-title":"The physiologic significance of plasma transport of vitamin D and metabolites","volume":"57","author":"Belsey","year":"1974","journal-title":"Am J Med."},{"key":"10.4158\/EP.14.1.6_bb0140","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(05)78933-9","article-title":"Redefining vitamin D insufficiency","volume":"351","author":"Malabanan","year":"1998","journal-title":"Lancet."},{"key":"10.4158\/EP.14.1.6_bb0145","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ajcn\/40.5.1057","article-title":"25-Hydroxyvitamin D and 1,25-dihydroxyvitamin D of D2 and D3 origin in maternal and umbilical cord serum after vitamin D2 supplementation in human pregnancy","volume":"40","author":"Markestad","year":"1984","journal-title":"Am J Clin Nutr."},{"key":"10.4158\/EP.14.1.6_bb0150","first-page":"2729","article-title":"Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density","volume":"84","author":"Adams","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.1.6_bb0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00223-003-0083-8","article-title":"Effect of vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter","volume":"74","author":"Rapuri","year":"2004","journal-title":"Calcif Tissue Int."},{"key":"10.4158\/EP.14.1.6_bb0160","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1210\/jcem-63-3-656","article-title":"Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects","volume":"63","author":"Clemens","year":"1986","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.1.6_bb0165","first-page":"378","article-title":"Effect of vitamin D2 and vitamin D3 on the serum concentrations of 1,25(OH)2D2 and 1,25(OH)2D3 in normal subjects","volume":"115","author":"Hartwell","year":"1987","journal-title":"Acta Endocrinol (Copenh)."},{"key":"10.4158\/EP.14.1.6_bb0170","first-page":"2308","article-title":"Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D","author":"Holick","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.1.6_bb0175","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20446853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20446853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/14R336221XR35N3U.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:48:38Z","timestamp":1761515318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20446853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1530891X20446853"],"URL":"https:\/\/doi.org\/10.4158\/ep.14.1.6","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The D-Lemia for Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.14.1.6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}